fashion -WSS

fashion

author：knowledge 2025-10-01 17:20:43 - browse：5

A product image of the Cue reader COVID-19 home use test — Businesswire via AP

The Food and Drug Administration warned consumers Monday to not use Cue Health’s at-home Covid-19 tests. This follows an FDA warning letter to the company last week that said Cue was not following the conditions stipulated in the emergency use authorizations for its tests.

The FDA letters said the tests could give false results. Specifically, the agency said that the company had changed how the electrochemical signals within the test device were generated, received, and interpreted — changes the FDA has not authorized. These changes decreased the stability of the tests and might lead to false results, the agency said.

The FDA warnings come near what might be the end of a spectacularly bumpy ride for the company. When Cue went public in 2021, it was valued at nearly $3 billion. It supplied tests for the NBA’s 2020 “bubble,” leading a Trump administration official to proclaim that if the test was “good enough for LeBron,” the administration would bring it to the American people — and it did, in a $481 million deal.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： How a Boston hospital is priming medical residents to use GPT

Wikipedia

WSS

The CDC's new social media misinformation war

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Surgery pushed Ben Carson to fame

5 dead in mass shooting on Caribbean island of St. Vincent: Police

A single Democrat is willing to weaken Medicare negotiation power

entertainment

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

Dobbs anniversary: the lost opportunity of abortion as health care

Top private equity targets in 2023: cardiology, clinical trials, lasers

Malaria cases in Florida and Texas: Here’s what you need to know

Medicare Advantage plans can’t deny care with AI, CMS warns

Affirmative action in medical school literally saved lives

Top private equity targets in 2023: cardiology, clinical trials, lasers

After affirmative action ruling, medical educators look to 'holistic review'

How a Boston hospital is priming medical residents to use GPT

Medical leaders decry Supreme Court decision on affirmative action

The CDC's new social media misinformation war

entertainment

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Judge denies Trump's request for new trial in E. Jean Carroll case

Surgery pushed Ben Carson to fame

There’s a way to spot data fakery. All journals should be using it

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Readout Newsletter: Amgen, Regeneron, BGI Group and more

hotspot

focus

Wikipedia

explore